TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,023 Cr | ₹2,585 Cr | ₹3,266 Cr | ₹2,368 Cr | ₹1,803 Cr |
What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,023 Cr |
| Mar2025 | ₹2,585 Cr |
| Mar2024 | ₹3,266 Cr |
| Mar2023 | ₹2,368 Cr |
| Mar2022 | ₹1,803 Cr |
How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,023 Cr | 16.93 | |
| Mar2025 | ₹2,585 Cr | -20.85 | |
| Mar2024 | ₹3,266 Cr | 37.92 | |
| Mar2023 | ₹2,368 Cr | 31.34 | |
| Mar2022 | ₹1,803 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹189,629.4 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,247.0 Cr | 1.9% | 3.5% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.3% |
2% |
35.9% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses